Retinal Toxicity & Degeneration Screening

Hydroxychloroquine Retinopathy

Chloroquine and hydroxychloroquine are prescribed long-term for lupus, rheumatoid arthritis, and other autoimmune conditions, and chronic use carries a well-recognized risk of toxic retinopathy. The appearance is distinctive: a paracentral ring of mottled hyper- and hypoautofluorescence around a relatively spared fovea, a pattern classically called a "bull's-eye" maculopathy. Parafoveal RPE damage drives the ring; the fovea itself is spared until later in the disease course.

Fundus autofluorescence catches this earliest. It marks RPE stress and atrophy as abnormal hyper- or hypoautofluorescence, sensitive enough to flag parafoveal change before it shows on a fundus photo. OCT is the other key modality, picking up early parafoveal photoreceptor and RPE disruption. Once bull's-eye maculopathy is identified, the causative drug should be discontinued in consultation with the prescribing physician. Monitoring has to continue even after the drug is stopped, because toxicity can keep progressing for a period after withdrawal.

This toxicity is dose- and duration-dependent, so screening follows a fixed schedule: a baseline exam at initiation, then annual screening starting around five years of use, sooner for patients on higher weight-based dosing or with renal impairment. OCT, visual field testing, and fundus autofluorescence together are the standard combination for catching retinal change before it becomes symptomatic.

Peripheral Retinoschisis

Acquired (degenerative) retinoschisis splits the retina into two layers and on a peripheral fundus exam can look superficially like a retinal detachment. The distinction matters: management differs substantially, and mistaking a schisis for a detachment risks sending a patient to unnecessary surgery. On fundus exam, retinoschisis appears as a well-demarcated, glistening, snowflake-like peripheral lesion. OCT settles the question directly. Retinoschisis shows splitting of the neurosensory retina into two layers, connected by thin, column-like intraretinal bridging strands, a signature a true retinal detachment does not share, since there the entire neurosensory retina lifts off the RPE as a single unit rather than splitting internally.

Wide-field imaging helps document how far peripheral retinoschisis extends over time. Standard fundus photography's limited field of view often cannot capture a lesion that sits this far into the periphery in one frame.

Cotton Wool Spots

Cotton wool spots are focal infarcts of the retinal nerve fiber layer, caused by interrupted axoplasmic flow at the level of the precapillary arterioles. They are a nonspecific marker of retinal ischemia, and they commonly appear alongside retinal hemorrhages in both diabetic and hypertensive retinopathy, where the two findings trace back to the same microvascular damage: hemorrhages from leaking vessels, cotton wool spots from the ischemia that follows. On their own they do not establish a diagnosis. Finding them is a prompt to look for, and when appropriate screen for, an underlying vascular or hematologic process.

Angioid Streaks

Angioid streaks are irregular, crack-like dehiscences radiating outward from the optic disc. They mark breaks in a Bruch's membrane that has become calcified, thickened, and abnormally brittle. On fundus exam they appear as pigmented, grayish, irregular lines forming a net-like pattern that extends into the macula and posterior pole. On fluorescein angiography they typically show as hyperfluorescent lines without associated leakage; on autofluorescence imaging they appear as hypoautofluorescent fissures, reflecting the RPE disruption along each streak.

The systemic association to know is pseudoxanthoma elasticum (PXE), a connective-tissue disorder of elastic fiber calcification. Angioid streaks are its most common ocular manifestation, arising from the same abnormal calcification within Bruch's membrane that affects the skin and blood vessels elsewhere in the disease. The streaks themselves are not visually threatening. The real risk is choroidal neovascularization breaking through one of the fragile breaks, so patients with known angioid streaks need ongoing surveillance for new subretinal fluid or hemorrhage, not a one-time look.

Related Topics

Continue exploring Retina & Vitreous: